MGO One Seven LLC Makes New Investment in Cardinal Health, Inc. (NYSE:CAH)

MGO One Seven LLC bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 3,716 shares of the company's stock, valued at approximately $439,000.

A number of other large investors have also added to or reduced their stakes in the business. Barclays PLC raised its position in shares of Cardinal Health by 8.2% in the third quarter. Barclays PLC now owns 707,404 shares of the company's stock valued at $78,183,000 after purchasing an additional 53,851 shares during the period. Wilmington Savings Fund Society FSB acquired a new position in Cardinal Health in the 3rd quarter valued at about $846,000. Franklin Resources Inc. raised its holdings in Cardinal Health by 6.6% in the 3rd quarter. Franklin Resources Inc. now owns 151,185 shares of the company's stock valued at $16,918,000 after acquiring an additional 9,385 shares during the period. Oddo BHF Asset Management Sas acquired a new stake in Cardinal Health during the third quarter worth approximately $497,000. Finally, Copley Financial Group Inc. bought a new stake in shares of Cardinal Health during the third quarter worth approximately $507,000. Institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Up 3.0 %

Shares of CAH traded up $4.17 during midday trading on Thursday, hitting $145.46. The company's stock had a trading volume of 4,025,794 shares, compared to its average volume of 2,199,618. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $147.20. The stock has a market capitalization of $35.14 billion, a price-to-earnings ratio of 27.14, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61. The company's fifty day simple moving average is $131.59 and its two-hundred day simple moving average is $124.49.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $2.15 by $0.20. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The firm had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. During the same quarter in the previous year, the firm earned $2.08 earnings per share. The business's quarterly revenue was up .0% on a year-over-year basis. On average, research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st were issued a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.39%. The ex-dividend date of this dividend was Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is 37.69%.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. UBS Group lifted their price target on Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a report on Tuesday. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and lifted their target price for the stock from $140.00 to $150.00 in a report on Wednesday, February 5th. TD Cowen upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and upped their price target for the company from $130.00 to $144.00 in a research note on Wednesday, January 8th. Citigroup lifted their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a "neutral" rating in a research note on Friday, January 10th. Finally, Evercore ISI upgraded shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price on the stock in a research report on Tuesday, January 7th. Four research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $142.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.